Drug manufacturers Xellia and Chartwell have notified 340B covered entities about possible refunds for overcharges. | Shutterstock

Two Drug Makers Providing Refunds for 340B Overcharges

Drug manufacturers Xellia and Chartwell have notified 340B covered entities about possible refunds for overcharges.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »